Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
The role of vasopressin in congestive heart failure Goldsmith SRCleve Clin J Med 2006[Sep]; 73 Suppl 3 (ä): S19-23Neurohormonal abnormalities contribute to the pathophysiology of congestive heart failure (CHF). Successful approaches to improving the prognosis of patients with CHF are based largely on therapeutic interruption of activated neurohormonal systems. The use of antagonists and inhibitors of the renin-angiotensin-aldosterone and sympathetic nervous systems has significantly improved clinical outcomes in CHF. Excessive secretion of arginine vasopressin (AVP) has the potential for deleterious effects on various physiologic processes in CHF Inhibition of AVP through vasopressin receptor antagonist therapy is a potentially beneficial new therapeutic approach to CHF|Angiotensin-Converting Enzyme Inhibitors/therapeutic use[MESH]|Antidiuretic Agents/therapeutic use[MESH]|Antidiuretic Hormone Receptor Antagonists[MESH]|Arginine Vasopressin/*therapeutic use[MESH]|Heart Failure/drug therapy/*physiopathology[MESH]|Humans[MESH]|Hyponatremia/drug therapy/etiology[MESH]|Neurotransmitter Agents/blood[MESH]|Prognosis[MESH]|Renin-Angiotensin System/drug effects/*physiology[MESH] |
